Log in to save to my catalogue

Characterization of the Pharmacokinetics of Human Recombinant Erythropoietin in Blood and Brain When...

Characterization of the Pharmacokinetics of Human Recombinant Erythropoietin in Blood and Brain When...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A201370864

Characterization of the Pharmacokinetics of Human Recombinant Erythropoietin in Blood and Brain When Administered Immediately after Lateral Fluid Percussion Brain Injury and Its Pharmacodynamic Effects on IL-1 β and MIP-2 in Rats

About this item

Full title

Characterization of the Pharmacokinetics of Human Recombinant Erythropoietin in Blood and Brain When Administered Immediately after Lateral Fluid Percussion Brain Injury and Its Pharmacodynamic Effects on IL-1 β and MIP-2 in Rats

Publisher

Mary Ann Liebert, Inc

Journal title

Journal of neurotrauma, 2008-10, Vol.25 (10), p.1179-1185

Language

English

Formats

Publication information

Publisher

Mary Ann Liebert, Inc

More information

Scope and Contents

Contents

This study sought to determine the bio-availability of recombinant human erythropoietin (EPO) in the brain and blood and its effects on the cerebral concentrations of the inflammatory mediators interleukin-1β (IL-1β) and macrophage-inflammation protein-2 (MIP-2) following lateral fluid percussion brain injury (FPI) in the rat. After induction of mo...

Alternative Titles

Full title

Characterization of the Pharmacokinetics of Human Recombinant Erythropoietin in Blood and Brain When Administered Immediately after Lateral Fluid Percussion Brain Injury and Its Pharmacodynamic Effects on IL-1 β and MIP-2 in Rats

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A201370864

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A201370864

Other Identifiers

ISSN

0897-7151

E-ISSN

1557-9042

DOI

10.1089/neu.2008.0591

How to access this item